2-(Cyclopentylidenemethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 500mg

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline, 98+%, 500mg

Cubeta de muestra ROTILABO® con tapa a presión, 90 ml, Estéril, 350 Unidad(es)

cis-N1-(tert-Butoxycarbonyl)-1,2-cyclohexanediamine>97.0%(GC)(T)1g

tert-Butyl (5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)carbamate, 98%, 1g

3,7-Dimethyloct-6-en-1-yn-3-ol, 95.0%, 100g

5-tert-butyl-1,3-thiazol-2-amine, 95.0%, 100mg

2-chloro-4-(2-naphthyl)pyrimidine, 5g

N-([1,1'-Biphenyl]-4-yl)-N-(4-(9-phenyl-9H-carbazol-3-yl)phenyl)-[1,1'-biphenyl]-4-amine, 250mg

Di-tert-butylchlorophosphine, 95.0%, 25g

4-Isopropyl-thiazol-2-ylamine, 95.0%, 5g

2-(2,2-Dimethyl-1,3-dioxolan-4-yl)ethanol, 95.0%, 5g

4-(3-HYDROXY-PROPOXY)-BENZOIC ACID METHYL ESTER, 95.0%, 1g